Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:7202
TSE:7202Auto

Assessing Isuzu Motors (TSE:7202) Valuation After Mixed Nine-Month Results And New 2026 Earnings Guidance

Isuzu Motors (TSE:7202) has drawn fresh attention after its Q3 2026 earnings call, where the company reported nine month sales of ¥2,511,521 million and issued full year revenue and profit guidance. See our latest analysis for Isuzu Motors. The earnings update and new full year guidance appear to sit alongside building momentum in the shares, with a 90 day share price return of 22.91% and a 1 year total shareholder return of 46.38% pointing to stronger sentiment recently than earlier in the...
TSE:7911
TSE:7911Commercial Services

A Look At TOPPAN Holdings (TSE:7911) Valuation After Mixed Nine Month Earnings Results

Why TOPPAN Holdings’ latest earnings matter for shareholders TOPPAN Holdings (TSE:7911) has drawn fresh attention after reporting nine month results to December 31, 2025, with sales of ¥1,322,805 million and net income of ¥58,125 million, compared with higher profit a year earlier. See our latest analysis for TOPPAN Holdings. The earnings release appears to be feeding into a mixed share price trend, with a 22.51% 90 day share price return contrasting with a 1.10% decline in the 1 year total...
NYSE:F
NYSE:FAuto

A Look At Ford (F) Valuation As Hybrid And Low Cost EV Plans And China Partnerships Advance

Ford Motor (F) is moving further into hybrids and low cost EVs while exploring joint ventures with Chinese automakers, a backdrop that gives fresh context to recent moves in Ford stock. See our latest analysis for Ford Motor. Those product plans, the recent 10 K outlining the Ford+ plan, and fresh talks about joint ventures with Chinese automakers come against a backdrop of a 59.91% 1 year total shareholder return and a 9.53% 90 day share price return, which suggests that momentum has been...
NYSE:INSP
NYSE:INSPMedical Equipment

A Look At Inspire Medical Systems (INSP) Valuation After Guidance Cut And Reimbursement Uncertainty

Inspire Medical Systems (INSP) has drawn fresh attention after cutting its 2026 outlook and highlighting reimbursement uncertainty tied to a new CPT code, alongside analyst rating changes and emerging legal scrutiny around prior disclosures. See our latest analysis for Inspire Medical Systems. The recent cut to 2026 guidance and reimbursement uncertainty has coincided with a sharp pullback, with a 30 day share price return of a 34.52% decline and a 1 year total shareholder return of a 66.46%...
TSX:MG
TSX:MGAuto Components

Assessing Magna International (TSX:MG) Valuation After Earnings, 2026 Outlook And Dividend Growth

Why Magna International (TSX:MG) Is in Focus After Its Latest Earnings Magna International (TSX:MG) is back on many investors' radars after its latest quarterly and full year 2025 results, an updated 2026 outlook, a higher dividend, and ongoing share buybacks. See our latest analysis for Magna International. The share price has moved sharply higher in recent months, with a 36.29% 90 day share price return and 76.83% 1 year total shareholder return. This suggests momentum has been building as...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

CRISPR Therapeutics Weighs Casgevy Expansion Against Losses And Pipeline Progress

CRISPR Therapeutics reported rapid commercial expansion of Casgevy, its FDA approved gene editing treatment for sickle cell disease, with patient initiations nearly tripling year over year. Coverage and reimbursement for Casgevy now extend across much of the US, Europe, and the Middle East, reaching a majority of eligible patients. The company is progressing in vivo gene editing programs targeting cardiovascular and autoimmune diseases, as well as oncology, adding momentum beyond recent...
NYSE:HCC
NYSE:HCCMetals and Mining

Assessing Warrior Met Coal (HCC) Valuation After Record 2025 Output And Early Blue Creek Ramp-Up

Warrior Met Coal (HCC) is back in the spotlight after reporting Q4 2025 results that combined record steelmaking coal production, the early ramp of its Blue Creek mine, and higher 2026 volume guidance. See our latest analysis for Warrior Met Coal. The recent Q4 2025 production records, early Blue Creek ramp up and updated 2026 guidance have arrived after a 90 day share price return of 12.11%, while the 1 year total shareholder return of 69.46% and 5 year total shareholder return of 272.55%...
NasdaqGS:CRNT
NasdaqGS:CRNTCommunications

Ceragon Networks (CRNT) Ends FY 2025 With Thin Profit Challenging Bullish Margin Narratives

Ceragon Networks (NasdaqGS:CRNT) has wrapped up FY 2025 with fourth quarter revenue of US$82.3 million and basic EPS of about US$0.001, alongside net income of roughly US$0.1 million. This keeps the full year on a trailing 12 month loss of US$2.1 million, or EPS of about US$0.02. The company has seen quarterly revenue range from US$88.7 million in Q1 2025 to US$82.3 million in Q4 2025, while basic EPS moved from a loss of about US$0.01 in the first half to small positive readings of roughly...
NYSE:NYT
NYSE:NYTMedia

New York Times Taps Magnite DV Plus For Mobile Ad Revenue Potential

New York Times Advertising and Magnite announced an expanded partnership to make Magnite DV+ the preferred platform for private marketplace deals. The agreement focuses on New York Times mobile in app ad supply, connecting advertisers with the publisher's mobile audience. The news relates to The New York Times Company (NYSE:NYT) and Magnite's role as an advertising technology partner. For you as an investor looking at NYSE:NYT, this move sits at the intersection of digital media and ad...
TSE:6976
TSE:6976Electronic

Taiyo Yuden (TSE:6976) Valuation Check After Strong Nine Month Earnings And New Guidance

Why Taiyo Yuden’s latest earnings matter for shareholders Taiyo Yuden (TSE:6976) has drawn fresh attention after reporting Q3 2026 earnings and issuing full year guidance. The company outlined expectations for net sales of ¥354,000 million and operating profit of ¥21,000 million. See our latest analysis for Taiyo Yuden. The Q3 2026 earnings call and full year guidance landed alongside a sharp shift in sentiment, with Taiyo Yuden’s 1 day share price return of 8.71% feeding into a 30 day share...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Krystal Biotech (KRYS) Net Margin Expansion Tests Bullish Long Term Profitability Narratives

Krystal Biotech (KRYS) closed FY 2025 with Q4 revenue of US$107.1 million and basic EPS of US$1.77, rounding out a year where trailing twelve month revenue reached US$389.1 million and EPS came in at US$7.08, alongside reported earnings growth of 129.7% year over year. Over the past six quarters in the dataset, revenue has moved from US$83.8 million in Q3 2024 to US$107.1 million in Q4 2025. Quarterly basic EPS tracked from US$0.95 to US$2.74 and then US$1.77, setting the backdrop for a...
WBAG:ANDR
WBAG:ANDRMachinery

Assessing Andritz (WBAG:ANDR) Valuation After Steady 2026 Earnings Guidance And Recent Share Price Momentum

Guidance sets the tone for Andritz stock Andritz (WBAG:ANDR) recently issued full year 2026 earnings guidance, telling investors it expects project activity to stay around current levels and revenue growth to be sustained. This message directly shaped the latest share price reaction. See our latest analysis for Andritz. The guidance update follows a strong run in the share price, with a 90 day share price return of 15.89% and a one year total shareholder return of 31.13%. This suggests that...
SEHK:1299
SEHK:1299Insurance

Does Adding Digital and HR Veterans to the Board Change the Bull Case for AIA Group (SEHK:1299)?

AIA Group Limited has appointed Ms. Shulamite N K Khoo and Mr. Ku Man as Independent Non-executive Directors to its board, effective 5 February 2026, drawing on their extensive experience across Asian financial services, technology and human capital management. The addition of Ms. Khoo, a former AIA Group Chief Human Resources Officer, and Mr. Ku, Chairman of WeBank, strengthens the board’s governance depth and digital financial expertise at a time when regional insurers are adapting to...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Zoetis (ZTS) Valuation Check After Earnings Beat Guidance Upgrade And Fresh Institutional Buying

Zoetis (ZTS) is back in focus after reporting quarterly and full year 2025 results that came in ahead of analyst expectations, along with 2026 guidance and fresh institutional buying interest. See our latest analysis for Zoetis. Despite the strong 2025 earnings update, recent trading has been subdued. A 7.24% 90 day share price return contrasts with a 1 year total shareholder return decline of 18.59%, suggesting longer term sentiment has been weaker even as shorter term momentum has picked...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Dollar Tree’s Higher Price Push Tests Brand Loyalty And Valuation

Dollar Tree (NasdaqGS:DLTR) is expanding its price range up to $10, moving away from its traditional single price model. The company is placing more emphasis on attracting wealthier shoppers, alongside its existing budget focused customer base. This shift has led to visible customer backlash and questions about how the brand will serve lower income consumers. For you as an investor, this is a meaningful change in how Dollar Tree, long known for a simple fixed price format, presents itself...
HLSE:UPM
HLSE:UPMForestry

Assessing UPM-Kymmene Oyj’s Valuation After Earnings, Maintained Dividend And 2026 EBIT Guidance

UPM-Kymmene Oyj (HLSE:UPM) has combined a proposed unchanged €1.50 per share dividend for 2025 with detailed 2026 EBIT guidance and full year 2025 results, giving investors fresh data on earnings and shareholder returns. See our latest analysis for UPM-Kymmene Oyj. The latest announcements around earnings, guidance and an unchanged dividend have arrived alongside a 30 day share price return of 9.94% and a 90 day share price return of 16.65%. The 1 year total shareholder return of a 2.60%...
NasdaqGS:FELE
NasdaqGS:FELEMachinery

Franklin Electric (FELE) Margin Compression To 6.9% Tests Bullish Profitability Narratives

Franklin Electric (FELE) just closed out FY 2025 with Q4 revenue of US$506.9 million and basic EPS of US$0.87, alongside trailing twelve month revenue of about US$2.1 billion and EPS of US$3.25. Over the past few quarters, the company has seen revenue range from US$455.2 million to US$587.4 million and quarterly EPS move between US$0.37 and US$1.32. This gives investors a clear look at how the top line and EPS have tracked into the latest print. At the same time, a softer net margin backdrop...
NYSE:COUR
NYSE:COURConsumer Services

Coursera (COUR) Valuation In Focus After Revenue Growth, Narrower Loss And New 2026 Guidance

Coursera (COUR) shares are in focus after the company released fourth quarter and full year 2025 results, reporting year-over-year revenue growth and a smaller full year net loss, along with new revenue guidance for 2026. See our latest analysis for Coursera. The latest earnings update and 2026 revenue guidance come after a mixed share price run. The 1 day share price return was 3.6%, while the 90 day share price return showed a 24.3% decline. The 1 year total shareholder return showed a...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Is Ally Financial (ALLY) Pricing Reflect Its Digital Banking And Auto Lending Prospects

If you are wondering whether Ally Financial's current share price lines up with its underlying value, this article walks through what the numbers are actually saying about the stock. The shares last closed at US$41.29, with returns of 8.7% over 1 year and 53.9% over 3 years. This is even though the stock has seen a 2.6% decline over 7 days, 5.3% over 30 days and 9.8% year to date. Recent attention on Ally Financial has focused on its role as a digital focused bank and auto lender, as...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Cisco Expands AI Networking And Security While Managing Supply Chain Strains

Cisco Systems (NasdaqGS:CSCO) has rolled out new AI-driven networking, security, and IT operations products, including agentic AI defenses and updates to its Silicon One portfolio. The company is expanding its AI reach through recent acquisitions and a new partnership with HCLTech to build next-generation customer engagement platforms. These launches come as the broader tech sector faces component supply challenges, including a DRAM shortage that is influencing Cisco's planning and...
NYSE:SUN
NYSE:SUNOil and Gas

Sunoco (SUN) Margin Compression Challenges Bullish Growth Narrative After FY 2025 Earnings

Sunoco (SUN) has wrapped up FY 2025 with fourth quarter revenue of US$8.6b and basic EPS of US$1.35, alongside net income excluding extra items of US$185m. This puts a clear spotlight on how efficiently those sales are turning into profit. The company has seen quarterly revenue move from US$5.3b and EPS of US$0.76 in Q4 2024 to US$8.6b and EPS of US$1.35 in Q4 2025. Trailing 12 month revenue stands at US$25.2b with EPS of US$3.55, setting the stage for investors to focus closely on how a 1.9%...
NYSE:AXP
NYSE:AXPConsumer Finance

Can American Express (AXP) Use Its Expanded NBA Deal To Deepen Its Premium Moat?

In February 2026, American Express and the NBA announced a multiyear renewal of their partnership across the NBA, WNBA, G League, USA Basketball and NBA Take-Two Media, expanding AmEx’s role into entitlement sponsorships, content, and a new connected benefits program with NBA ID. The broadened basketball partnership deepens American Express’s access to engaged sports fans while layering in exclusive cardmember perks that could reinforce its premium brand positioning and customer...
TSX:ENB
TSX:ENBOil and Gas

Enbridge Dual Pipeline Corridor Progress Weighed Against Valuation And Dividend Risks

Enbridge (TSX:ENB) is moving ahead with a dual pipeline corridor between Dawson Creek and Ridley Island after its acquisition of Spectra Energy. The company is working with Kitsault Energy to renew and advance a previously secured permit tied to this corridor. This development follows earlier setbacks with the Northern Gateway project and represents a shift in Enbridge's West Coast export approach. For you as an investor, this is directly tied to how Enbridge earns fees from transporting...
SEHK:1093
SEHK:1093Pharmaceuticals

Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After New Obesity And Pain Drug Trial Clearances

CSPC Pharmaceutical Group (SEHK:1093) has drawn fresh attention after securing regulatory clearance to begin clinical trials for two long acting drug candidates targeting obesity, weight related conditions, and post operative pain. See our latest analysis for CSPC Pharmaceutical Group. The recent regulatory clearances arrive after a strong run, with CSPC Pharmaceutical Group’s 90 day share price return of 35.40% and 1 year total shareholder return of 118.26% pointing to building momentum...